Richard Steinhart's Trading History
| ATNMActinium Pharmaceuticals | Sep 04, 2026 | Director | Uninformative Buy | ― | $93.41K | |
| BTAIQBioxcel Therapeutics | Jun 17, 2026 | CFO | Uninformative Buy | 40.60 | $342.36 | |
| ATOSAtossa Therapeutics | May 14, 2026 | Director | Uninformative Buy | ― | $21.70K | |
| SSKNStrata Skin Sciences | Aug 08, 2013 | CFO | Uninformative Buy | ― | $2.25K | |
| TGTXTG Therapeutics | ― | Director | ― | $689.25K |
You May Also Like
Richard Steinhart insider profile FAQ
What is the percentage of profitable transactions made by Richard Steinhart?
The percentage of profitable transactions made by Richard Steinhart is 75%.
What is the average return per transaction made by Richard Steinhart?
The average return per transaction made by Richard Steinhart is 15.50%.
What stocks does Richard Steinhart hold?
Richard Steinhart holds: ATNM, ATOS, BTAIQ, SSKN, TGTX stocks.
What was Richard Steinhart's most profitable transaction?
Richard Steinhart’s most profitable transaction was an Informative Buy of BTAIQ stock on November 30, 2018. The return on the trade was 28.70%.
What is Richard Steinhart's role in Actinium Pharmaceuticals?
Richard Steinhart's role in Actinium Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.